633227436	633227436	CD	B-NP	O
|	|	NN	I-NP	O
CBMC	CBMC	NN	I-NP	O
|	|	NN	I-NP	O
78632771	78632771	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
2125144	2125144	CD	B-NP	O
|	|	CC	I-NP	O
10/9/2005	10/9/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
RIGHT	RIGHT	NNP	I-NP	I-protein
KNEE	KNEE	NNP	I-NP	I-protein
EFFUSION	EFFUSION	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/21/2005	3/21/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/14/2005	11/14/2005	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
REDWINE	REDWINE	NNP	B-NP	O
,	,	,	O	O
KENNY	KENNY	NNP	B-NP	O
M.D.	M.D.	NNP	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DIAGNOSES	DIAGNOSES	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Knee	Knee	NN	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Chronic	Chronic	JJ	B-NP	O
venous	venous	JJ	I-NP	O
stasis	stasis	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Lithium	Lithium	NN	B-NP	O
toxicity	toxicity	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Obesity	Obesity	NN	B-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
50-year-old	50-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
obesity	obesity	NN	B-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
a	a	DT	B-NP	O
schizophrenia	schizophrenia	NN	I-NP	O
and	and	CC	O	O
bipolar	bipolar	JJ	B-NP	O
disorder	disorder	NN	I-NP	O
,	,	,	O	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
right	right	JJ	B-NP	O
knee	knee	NN	I-NP	O
swelling	swelling	NN	I-NP	O
,	,	,	O	O
redness	redness	NN	B-NP	O
and	and	CC	I-NP	O
pain	pain	NN	I-NP	O
for	for	IN	B-PP	O
one	one	CD	B-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
lives	live	VBZ	B-VP	O
alone	alone	RB	B-ADVP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
two	two	CD	B-NP	O
brothers	brother	NNS	I-NP	O
who	who	WP	B-NP	O
periodically	periodically	RB	B-ADVP	O
check	check	VBP	B-VP	O
in	in	RP	B-PRT	O
on	on	IN	B-PP	O
her	her	PRP	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
visited	visit	VBN	I-VP	O
by	by	IN	B-PP	O
her	her	PRP$	B-NP	O
brother	brother	NN	I-NP	O
yesterday	yesterday	NN	B-NP	O
and	and	CC	O	O
found	find	VBD	B-VP	O
that	that	IN	B-SBAR	O
her	her	PRP$	B-NP	O
right	right	JJ	I-NP	O
knee	knee	NN	I-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
swollen	swell	VBN	I-VP	O
red	red	JJ	B-NP	O
and	and	CC	I-NP	O
tender	tender	NN	I-NP	O
for	for	IN	B-PP	O
about	about	IN	B-NP	O
a	a	DT	I-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

After	After	IN	B-SBAR	O
he	he	PRP	B-NP	O
noted	note	VBD	B-VP	O
this	this	DT	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
brought	bring	VBD	B-VP	O
her	her	PRP	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
department	department	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
states	state	VBZ	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
leg	leg	NN	I-NP	O
has	have	VBZ	B-VP	O
made	make	VBN	I-VP	O
it	it	PRP	B-NP	O
impossible	impossible	JJ	B-ADJP	O
for	for	IN	B-SBAR	O
her	her	PRP	B-NP	O
to	to	TO	B-VP	O
ambulate	ambulate	VB	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
trauma	trauma	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
area	area	NN	I-NP	O
recently	recently	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
denies	deny	VBZ	B-VP	O
fevers	fever	NNS	B-NP	O
,	,	,	O	O
chills	chill	NNS	B-NP	O
,	,	,	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
or	or	CC	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
no	no	DT	B-NP	O
nausea	nausea	NN	I-NP	O
,	,	,	I-NP	O
vomiting	vomiting	NN	I-NP	O
,	,	,	I-NP	O
constipation	constipation	NN	I-NP	O
or	or	CC	I-NP	O
diarrhea	diarrhea	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Ovarian	Ovarian	JJ	B-NP	O
cystadenofibroma	cystadenofibroma	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
TAH-BSO	TAH-BSO	NN	I-NP	O
in	in	IN	B-PP	O
8/18	8/18	CD	B-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

Obesity	Obesity	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Diabetes	Diabete	NNS	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Hyperlipidemia	Hyperlipidemia	NN	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Schizophrenia	Schizophrenia	NNP	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Bipolar	Bipolar	JJ	B-NP	O
disorder	disorder	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Obstructive	Obstructive	JJ	B-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
home	home	NN	B-NP	B-protein
BiPAP	BiPAP	NN	I-NP	I-protein
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

History	History	NN	B-NP	O
of	of	IN	B-PP	O
laparoscopy	laparoscopy	NN	B-NP	O
for	for	IN	B-PP	O
infertility	infertility	NN	B-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
known	know	VBN	I-NP	O
drug	drug	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Lisinopril	Lisinopril	NNP	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Lipitor	Lipitor	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Klonopin	Klonopin	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

MetroGel	MetroGel	NN	B-NP	O
p.o.	p.o.	NN	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Lithium	Lithium	NN	B-NP	O
900	900	CD	I-NP	O
mg	mg	NN	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Acebutolol	Acebutolol	NN	B-NP	O
200	200	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Risperdal	Risperdal	JJ	B-NP	O
0.5	0.5	CD	I-NP	O
mg	mg	NN	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
lives	live	VBZ	B-VP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
alone	alone	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
smokes	smoke	VBZ	B-VP	O
tobacco	tobacco	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
denies	deny	VBZ	B-VP	O
ethanol	ethanol	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
does	do	VBZ	B-VP	O
drink	drink	VB	I-VP	O
several	several	JJ	B-NP	O
bottles	bottle	NNS	I-NP	O
of	of	IN	B-PP	O
soda	soda	NN	B-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
brother	brother	NN	I-NP	O
,	,	,	O	O
Willard	Willard	NNP	B-NP	O
Kloock	Kloock	NNP	I-NP	O
,	,	,	O	O
did	do	VBD	B-VP	O
involve	involve	VB	I-VP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
care	care	NN	I-NP	O
;	;	:	O	O
his	his	PRP$	B-NP	O
phone	phone	NN	I-NP	O
number	number	NN	I-NP	O
is	be	VBZ	B-VP	O
919-737-1462	919-737-1462	CD	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
can	can	MD	B-VP	O
also	also	RB	I-VP	O
be	be	VB	I-VP	O
reached	reach	VBN	I-VP	O
at	at	IN	B-PP	O
813-553-9989	813-553-9989	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
other	other	JJ	I-NP	O
brother	brother	NN	I-NP	O
,	,	,	O	O
Merrill	Merrill	NNP	B-NP	O
Luersen	Luersen	NNP	I-NP	O
,	,	,	O	O
is	be	VBZ	B-VP	O
also	also	RB	I-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
care	care	NN	I-NP	O
and	and	CC	O	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
reached	reach	VBN	I-VP	O
at	at	IN	B-PP	O
561-831-3385	561-831-3385	CD	B-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
Temperature	Temperature	NN	B-NP	B-protein
97.5	97.5	CD	I-NP	I-protein
,	,	,	O	O
pulse	pulse	NN	B-NP	O
42	42	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
107/58	107/58	CD	I-NP	O
,	,	,	O	O
respirations	respiration	NNS	B-NP	O
20	20	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
oxygen	oxygen	NN	B-NP	O
saturation	saturation	NN	I-NP	O
97	97	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
general	general	JJ	B-ADJP	O
,	,	,	O	O
this	this	DT	B-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
obese	obese	JJ	I-NP	O
female	female	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
Spanish-speaking	Spanish-speaking	JJ	B-ADJP	O
mostly	mostly	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
appears	appear	VBZ	B-VP	O
unkempt	unkempt	JJ	B-ADJP	O
and	and	CC	O	O
in	in	IN	B-PP	O
discomfort	discomfort	NN	B-NP	O
somewhat	somewhat	RB	B-ADVP	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
her	her	PRP$	B-NP	O
right	right	JJ	I-NP	O
knee	knee	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-NP	O
exam	exam	NN	I-NP	O
shows	show	VBZ	B-VP	O
bradycardia	bradycardia	NN	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
normal	normal	JJ	B-NP	O
S1	S1	NN	I-NP	B-protein
and	and	CC	O	O
S2	S2	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
2/6	2/6	CD	B-NP	O
systolic	systolic	JJ	I-NP	O
ejection	ejection	NN	I-NP	O
murmur	murmur	NN	I-NP	O
heard	hear	VBD	B-VP	O
best	well	RBS	B-ADVP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
upper	upper	JJ	I-NP	O
sternal	sternal	JJ	I-NP	O
border	border	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
chest	chest	NN	I-NP	O
exam	exam	NN	I-NP	O
showed	show	VBD	B-VP	O
some	some	DT	B-NP	O
low	low	JJ	I-NP	O
soft	soft	JJ	I-NP	O
rumbling	rumble	VBG	I-NP	O
sounds	sound	NNS	I-NP	O
with	with	IN	B-PP	O
inspiration	inspiration	NN	B-NP	O
and	and	CC	I-NP	O
expiration	expiration	NN	I-NP	O
,	,	,	O	O
otherwise	otherwise	RB	B-ADVP	O
,	,	,	O	O
clear	clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
was	be	VBD	B-VP	O
distended	distend	VBN	I-VP	O
and	and	CC	O	O
obese	obese	JJ	B-ADJP	O
.	.	.	O	O

There	There	EX	B-NP	O
are	be	VBP	B-VP	O
positive	positive	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
no	no	DT	B-NP	O
palpable	palpable	JJ	I-NP	O
liver	liver	NN	I-NP	O
and	and	CC	I-NP	O
spleen	spleen	NN	I-NP	O
.	.	.	O	O

Extremity	Extremity	NN	B-NP	O
exam	exam	NN	I-NP	O
showed	show	VBD	B-VP	O
uncut	uncut	JJ	B-NP	O
nails	nail	NNS	I-NP	O
on	on	IN	B-PP	O
upper	upper	JJ	B-NP	O
and	and	CC	I-NP	O
lower	low	JJR	I-NP	O
extremities	extremity	NNS	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
right	right	JJ	I-NP	O
leg	leg	NN	I-NP	O
was	be	VBD	B-VP	O
greater	great	JJR	B-ADJP	O
in	in	IN	B-PP	O
size	size	NN	B-NP	O
than	than	IN	B-PP	O
her	her	PRP$	B-NP	O
left	left	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
both	both	DT	B-NP	O
show	show	VBP	B-VP	O
significant	significant	JJ	B-NP	O
2-3	2-3	NN	I-NP	O
+	+	SYM	B-VP	O
pitting	pitting	NN	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
ankle	ankle	NN	I-NP	O
area	area	NN	I-NP	O
,	,	,	O	O
there	there	EX	B-NP	O
appears	appear	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
chronic	chronic	JJ	B-NP	O
venous	venous	JJ	I-NP	O
stasis	stasis	NN	I-NP	O
changes	change	NNS	I-NP	O
with	with	IN	B-PP	O
hyperpigmented	hyperpigmented	JJ	B-NP	O
patch	patch	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
are	be	VBP	B-VP	O
less	less	RBR	B-NP	O
chronic	chronic	JJ	I-NP	O
venous	venous	JJ	I-NP	O
stasis	stasis	NN	I-NP	O
changes	change	NNS	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
some	some	DT	B-NP	O
mild	mild	JJ	I-NP	O
erythema	erythema	NN	I-NP	O
around	around	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
knee	knee	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
area	area	NN	I-NP	O
of	of	IN	B-PP	O
redness	redness	NN	B-NP	O
was	be	VBD	B-VP	O
poorly	poorly	RB	I-VP	O
demarcated	demarcate	VBN	I-VP	O
and	and	CC	O	O
mildly	mildly	RB	B-VP	O
blanching	blanch	VBG	I-VP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
painful	painful	JJ	B-NP	O
passive	passive	JJ	I-NP	O
motion	motion	NN	I-NP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
right	right	JJ	I-NP	O
knee	knee	NN	I-NP	O
.	.	.	O	O

Neuro	Neuro	NN	B-NP	O
exam	exam	NN	I-NP	O
was	be	VBD	B-VP	O
grossly	grossly	RB	B-ADJP	O
intact	intact	JJ	I-ADJP	O
and	and	CC	I-ADJP	O
nonfocal	nonfocal	JJ	I-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
coarse	coarse	NN	I-NP	O
tremor	tremor	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
upper	upper	JJ	I-NP	O
and	and	CC	I-NP	O
lower	low	JJR	I-NP	O
extremities	extremity	NNS	I-NP	O
when	when	WRB	B-ADVP	O
asked	ask	VBN	B-VP	O
to	to	TO	B-VP	O
use	use	VB	I-VP	O
these	these	DT	B-NP	O
extremities	extremity	NNS	I-NP	O
for	for	IN	B-PP	O
motion	motion	NN	B-NP	O
.	.	.	O	O

DIAGNOSTIC	DIAGNOSTIC	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
Electrolytes	Electrolyte	NNS	B-NP	O
were	be	VBD	B-VP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
potassium	potassium	NN	I-NP	O
of	of	IN	B-PP	O
5.8	5.8	CD	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
1.6	1.6	CD	B-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
raised	raise	VBN	I-VP	O
from	from	IN	B-PP	O
previous	previous	JJ	B-NP	O
creatinine	creatinine	NN	I-NP	O
in	in	IN	B-PP	O
2004	2004	CD	B-NP	O
of	of	IN	B-PP	O
1.0	1.0	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
liver	liver	NN	I-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
unremarkable	unremarkable	JJ	B-ADJP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
was	be	VBD	B-VP	O
45.5	45.5	CD	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
UA	UA	NN	I-NP	O
done	do	VBN	B-VP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
was	be	VBD	B-VP	O
bland	bland	JJ	B-ADJP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
urine	urine	NN	B-NP	B-cell_line
cultures	culture	NNS	I-NP	I-cell_line
grew	grow	VBD	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
a	a	DT	B-NP	O
1000	1000	CD	I-NP	O
CFU/mL	CFU/mL	NN	I-NP	O
of	of	IN	B-PP	O
coag-negative	coag-negative	JJ	B-NP	O
Staphylococcus	Staphylococcus	NNP	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
right	right	JJ	I-NP	O
knee	knee	NN	I-NP	O
film	film	NN	I-NP	O
showed	show	VBD	B-VP	O
mild	mild	JJ	B-NP	O
effusion	effusion	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
fracture	fracture	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
effusion	effusion	NN	I-NP	O
was	be	VBD	B-VP	O
tapped	tap	VBN	I-VP	O
and	and	CC	O	O
showed	show	VBD	B-VP	O
20	20	CD	B-NP	O
white	white	JJ	I-NP	O
blood	blood	NN	I-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
810	810	CD	B-NP	O
red	red	JJ	I-NP	O
blood	blood	NN	I-NP	O
cells	cell	NNS	I-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
the	the	DT	B-NP	O
white	white	JJ	I-NP	B-cell_type
blood	blood	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
21	21	CD	B-NP	O
%	%	NN	I-NP	O
were	be	VBD	B-VP	O
PMNs	PMN	NNS	B-NP	B-cell_type
and	and	CC	O	O
75	75	CD	B-NP	O
%	%	NN	I-NP	O
were	be	VBD	B-VP	O
lymphocytes	lymphocyte	NNS	B-NP	B-cell_type
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
crystals	crystal	NNS	I-NP	O
seen	see	VBN	B-VP	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
organisms	organism	NNS	I-NP	O
seen	see	VBN	B-VP	O
.	.	.	O	O

ASSESSMENT	ASSESSMENT	NN	B-NP	O
:	:	:	O	O
Ms.	Ms.	NNP	B-NP	O
Fought	Fought	NNP	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
50-year-old	50-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
bipolar	bipolar	JJ	B-NP	O
disorder	disorder	NN	I-NP	O
,	,	,	O	O
schizophrenia	schizophrenia	NN	B-NP	O
,	,	,	O	O
obstructive	obstructive	JJ	B-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
one	one	CD	B-NP	O
week	week	NN	I-NP	O
of	of	IN	B-PP	O
worsening	worsen	VBG	B-VP	O
right	right	JJ	B-NP	O
knee	knee	NN	I-NP	O
redness	redness	NN	I-NP	O
,	,	,	O	O
swelling	swelling	NN	B-NP	O
and	and	CC	I-NP	O
pain	pain	NN	I-NP	O
causing	cause	VBG	I-NP	O
immobility	immobility	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
BY	BY	NN	I-NP	O
SYSTEM/PROBLEM	SYSTEM/PROBLEM	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Leg	Leg	NNP	B-NP	O
swelling	swelling	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
differential	differential	JJ	I-NP	O
diagnosis	diagnosis	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
considered	consider	VBN	I-VP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
leg	leg	NN	I-NP	O
swelling	swelling	NN	I-NP	O
included	include	VBD	B-VP	O
deep	deep	JJ	B-NP	O
venous	venous	JJ	I-NP	O
thrombosis	thrombosis	NN	I-NP	O
versus	versus	IN	B-PP	O
cellulitis	cellulitis	NN	B-NP	O
versus	versus	IN	B-PP	O
septic	septic	JJ	B-NP	O
joints	joint	NNS	I-NP	O
versus	versus	IN	B-PP	O
gout	gout	NN	B-NP	O
versus	versus	CC	O	O
chronic	chronic	JJ	B-NP	O
lymphedema	lymphedema	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
acute	acute	JJ	I-NP	O
worsening	worsening	NN	I-NP	O
.	.	.	O	O

Infectious	Infectious	JJ	B-NP	O
causes	cause	NNS	I-NP	O
were	be	VBD	B-VP	O
considered	consider	VBN	I-VP	O
less	less	RBR	B-ADJP	O
likely	likely	JJ	I-ADJP	O
given	give	VBN	B-PP	O
the	the	DT	B-NP	O
fact	fact	NN	I-NP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
white	white	JJ	I-NP	O
count	count	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
significantly	significantly	RB	I-VP	O
elevated	elevate	VBN	I-VP	O
,	,	,	O	O
-LRB-	-LRB-	HYPH	O	B-protein
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
10.5	10.5	CD	B-NP	O
with	with	IN	B-PP	O
75	75	CD	B-NP	O
%	%	NN	I-NP	O
polys	poly	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
80	80	CD	B-NP	O
%	%	NN	I-NP	O
lymphs	lymph	NNS	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
in	in	IN	B-PP	O
fact	fact	NN	B-NP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
not	not	RB	I-VP	O
had	have	VBN	I-VP	O
any	any	DT	B-NP	O
fever	fever	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
empirically	empirically	RB	B-ADVP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
this	this	DT	B-NP	O
diagnosis	diagnosis	NN	I-NP	O
was	be	VBD	B-VP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
ruled	rule	VBN	I-VP	O
out	out	RP	B-PRT	O
initially	initially	RB	B-ADVP	O
with	with	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
and	and	CC	I-NP	O
Unasyn	Unasyn	NN	I-NP	O
and	and	CC	O	O
then	then	RB	B-ADVP	O
with	with	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
therapeutic	therapeutic	JJ	B-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
heparin	heparin	NN	B-NP	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
the	the	DT	B-NP	O
concern	concern	NN	I-NP	O
of	of	IN	B-PP	O
pain	pain	NN	B-NP	O
and	and	CC	O	O
swelling	swell	VBG	B-VP	O
asymmetrically	asymmetrically	RB	B-ADVP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
lower	low	JJR	I-NP	O
extremities	extremity	NNS	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
continued	continue	VBD	B-VP	O
until	until	IN	B-SBAR	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
Doppler	Doppler	NNP	I-NP	O
studies	study	NNS	I-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
deep	deep	JJ	I-NP	O
venous	venous	JJ	I-NP	O
thrombosis	thrombosis	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
femoral	femoral	JJ	I-NP	O
or	or	CC	I-NP	O
left	left	JJ	I-NP	O
popliteal	popliteal	JJ	I-NP	O
veins	vein	NNS	I-NP	O
.	.	.	O	O

Uric	Uric	JJ	B-NP	O
acid	acid	NN	I-NP	O
levels	level	NNS	I-NP	O
were	be	VBD	B-VP	O
checked	check	VBN	I-VP	O
and	and	CC	O	O
shown	show	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
elevated	elevate	VBN	I-VP	O
at	at	IN	B-PP	O
8.6	8.6	CD	B-NP	O
and	and	CC	O	O
again	again	RB	B-ADVP	O
at	at	IN	B-PP	O
8.0	8.0	CD	B-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
values	value	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
gout	gout	NN	B-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
problem	problem	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
there	there	EX	B-NP	O
are	be	VBP	B-VP	O
no	no	DT	B-NP	O
crystals	crystal	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
synovial	synovial	JJ	I-NP	O
fluid	fluid	NN	I-NP	O
making	make	VBG	B-VP	O
this	this	DT	B-NP	O
diagnosis	diagnosis	NN	I-NP	O
also	also	RB	B-ADVP	O
less	less	RBR	B-ADJP	O
likely	likely	JJ	I-ADJP	O
.	.	.	O	O

Over	Over	IN	B-PP	O
her	her	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
swelling	swelling	NN	I-NP	O
,	,	,	I-NP	O
tenderness	tenderness	NN	I-NP	O
and	and	CC	I-NP	O
redness	redness	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
knee	knee	NN	I-NP	O
decreased	decrease	VBD	B-VP	O
significantly	significantly	RB	B-ADVP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
left	left	JJ	I-NP	O
knee	knee	NN	I-NP	O
began	begin	VBD	B-VP	O
to	to	TO	I-VP	O
cause	cause	VB	I-VP	O
her	her	PRP$	B-NP	O
significant	significant	JJ	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
requiring	require	VBG	B-VP	O
oxycodone	oxycodone	NN	B-NP	O
,	,	,	O	O
Tylenol	Tylenol	NN	B-NP	O
and	and	CC	O	O
lidocaine	lidocaine	NN	B-NP	O
patch	patch	NN	I-NP	O
.	.	.	O	O

Because	Because	IN	B-PP	O
of	of	IN	I-PP	O
concerning	concern	VBG	B-VP	O
renal	renal	JJ	B-NP	O
function	function	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
1.6	1.6	CD	B-NP	O
from	from	IN	B-PP	O
1.0	1.0	CD	B-NP	O
,	,	,	O	O
NSAIDs	NSAID	NNS	B-NP	O
were	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
initially	initially	RB	B-ADVP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
trended	trend	VBD	B-VP	O
down	down	RB	B-ADVP	O
to	to	TO	B-PP	O
1.2	1.2	CD	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
so	so	IN	B-SBAR	O
she	she	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
with	with	IN	B-PP	O
NSAIDs	NSAID	NNS	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
are	be	VBP	B-VP	O
expected	expect	VBN	I-VP	O
to	to	TO	I-VP	O
help	help	VB	I-VP	O
her	her	PRP$	B-NP	B-protein
musculoskeletal	musculoskeletal	JJ	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
.	.	.	O	O

While	While	IN	B-SBAR	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
received	receive	VBD	B-VP	O
Physical	Physical	JJ	B-NP	O
Therapy	Therapy	NN	I-NP	O
who	who	WP	B-NP	O
evaluated	evaluate	VBD	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
and	and	CC	O	O
suggested	suggest	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
would	would	MD	B-VP	O
benefit	benefit	VB	I-VP	O
from	from	IN	B-PP	O
continued	continue	VBN	B-NP	O
direct	direct	JJ	I-NP	O
physical	physical	JJ	I-NP	O
therapy	therapy	NN	I-NP	O
to	to	TO	B-VP	O
address	address	VB	I-VP	O
functional	functional	JJ	B-NP	O
mobility	mobility	NN	I-NP	O
retraining	retraining	NN	I-NP	O
.	.	.	O	O

Short-terms	Short-term	NNS	B-NP	O
goals	goal	NNS	I-NP	O
included	include	VBD	B-VP	O
ambulate	ambulate	VBP	B-VP	O
50	50	CD	B-NP	O
feet	foot	NNS	I-NP	O
with	with	IN	B-PP	O
minimal	minimal	JJ	B-NP	O
assistance	assistance	NN	I-NP	O
with	with	IN	B-PP	O
restrictive	restrictive	JJ	B-NP	O
device	device	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
to	to	TO	B-VP	O
tolerate	tolerate	VB	I-VP	O
out	out	IN	B-PP	O
of	of	IN	B-PP	O
bed	bed	NN	B-NP	O
to	to	TO	B-PP	O
chair	chair	NN	B-NP	O
for	for	IN	B-PP	O
30	30	CD	B-NP	O
minutes	minute	NNS	I-NP	O
with	with	IN	B-PP	O
reports	report	NNS	B-NP	O
of	of	IN	B-PP	O
fatigue	fatigue	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Lithium	Lithium	NN	B-NP	O
toxicity	toxicity	NN	I-NP	O
:	:	:	O	O
Because	Because	IN	B-PP	O
of	of	IN	I-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
coarse	coarse	NN	I-NP	O
tremor	tremor	NN	I-NP	O
,	,	,	O	O
bradycardia	bradycardia	NN	B-NP	O
,	,	,	O	O
hypotension	hypotension	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
fact	fact	NN	I-NP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
taking	take	VBG	I-VP	O
lithium	lithium	NN	B-NP	O
,	,	,	O	O
encouraged	encourage	VBD	B-VP	O
her	her	PRP$	B-NP	O
lithium	lithium	NN	I-NP	O
level	level	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
checked	check	VBN	I-VP	O
which	which	WDT	B-NP	O
came	come	VBD	B-VP	O
back	back	RB	I-VP	O
elevated	elevate	VBN	I-VP	O
at	at	IN	B-PP	O
2.7	2.7	CD	B-NP	O
,	,	,	O	O
-LRB-	-LRB-	HYPH	B-NP	O
normal	normal	JJ	I-NP	O
levels	level	NNS	I-NP	O
between	between	IN	B-PP	O
0.5	0.5	CD	B-NP	O
and	and	CC	I-NP	O
1.3	1.3	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
level	level	NN	I-NP	O
was	be	VBD	B-VP	O
concerning	concern	VBG	I-VP	O
because	because	IN	B-SBAR	O
lithium	lithium	NN	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
very	very	RB	I-NP	O
narrow	narrow	JJ	I-NP	O
therapeutic	therapeutic	JJ	I-NP	O
window	window	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
lithium	lithium	NN	I-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
IV	IV	CD	B-NP	O
fluids	fluid	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
allowed	allow	VBD	B-VP	O
her	her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
to	to	TO	B-VP	O
decrease	decrease	VB	I-VP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
somewhat	somewhat	RB	I-VP	O
dehydrated	dehydrate	VBN	I-VP	O
on	on	IN	B-PP	O
presentation	presentation	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
department	department	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
lithium	lithium	NN	I-NP	O
toxicity	toxicity	NN	I-NP	O
could	could	MD	B-VP	O
in	in	IN	B-PP	O
part	part	NN	B-NP	O
explain	explain	VB	B-VP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
bradycardia	bradycardia	NN	I-NP	O
and	and	CC	I-NP	O
hypotension	hypotension	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
her	her	PRP$	B-NP	O
hypokalemia	hypokalemia	NN	I-NP	O
and	and	CC	I-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
psych	psych	NN	I-NP	O
consult	consult	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
to	to	TO	I-VP	O
address	address	VB	I-VP	O
the	the	DT	B-NP	O
question	question	NN	I-NP	O
of	of	IN	B-PP	O
when	when	WRB	B-ADVP	O
and	and	CC	I-ADVP	O
how	how	WRB	I-ADVP	O
to	to	TO	B-VP	O
restart	restart	VB	I-VP	O
the	the	DT	B-NP	O
lithium	lithium	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
psych	psych	NN	I-NP	O
consultant	consultant	NN	I-NP	O
suggested	suggest	VBD	B-VP	O
to	to	TO	I-VP	O
check	check	VB	I-VP	O
lithium	lithium	NN	B-NP	O
levels	level	NNS	I-NP	O
daily	daily	RB	B-ADVP	O
until	until	IN	B-SBAR	O
they	they	PRP	B-NP	O
fell	fall	VBD	B-VP	O
below	below	IN	B-PP	O
0.5	0.5	CD	B-NP	O
and	and	CC	O	O
then	then	RB	O	O
should	should	MD	B-VP	O
restart	restart	VB	I-VP	O
the	the	DT	B-NP	O
lithium	lithium	NN	I-NP	O
at	at	IN	B-PP	O
300	300	CD	B-NP	O
mg	mg	NN	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
lithium	lithium	NN	I-NP	O
level	level	NN	I-NP	O
was	be	VBD	B-VP	O
at	at	IN	B-PP	O
1.12	1.12	CD	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
level	level	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
checked	check	VBN	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
nursing	nursing	NN	I-NP	O
facility	facility	NN	I-NP	O
and	and	CC	I-NP	O
lithium	lithium	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
restarted	restart	VBN	I-VP	O
at	at	IN	B-PP	O
300	300	CD	B-NP	O
mg	mg	NN	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
when	when	WRB	B-ADVP	O
the	the	DT	B-NP	O
level	level	NN	I-NP	O
is	be	VBZ	B-VP	O
0.5	0.5	CD	B-NP	O
or	or	CC	O	O
below	below	IN	B-ADVP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
From	From	IN	B-PP	O
a	a	DT	B-NP	O
pump	pump	NN	I-NP	O
standpoint	standpoint	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
hypovolemic	hypovolemic	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
hypotensive	hypotensive	JJ	I-ADJP	O
on	on	IN	B-PP	O
presentation	presentation	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
department	department	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
responded	respond	VBD	B-VP	O
well	well	RB	B-ADVP	O
to	to	TO	B-PP	O
normal	normal	JJ	B-NP	O
saline	saline	NN	I-NP	O
fluid	fluid	NN	I-NP	O
boluses	bolus	NNS	I-NP	O
and	and	CC	O	O
given	give	VBN	B-VP	O
a	a	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
3	3	CD	B-NP	O
liters	liter	NNS	I-NP	O
over	over	IN	B-PP	O
her	her	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

From	From	IN	B-PP	O
a	a	DT	B-NP	O
rhythm	rhythm	NN	I-NP	O
standpoint	standpoint	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
bradycardia	bradycardia	NN	I-NP	O
was	be	VBD	B-VP	O
resolved	resolve	VBN	I-VP	O
of	of	IN	B-PP	O
either	either	CC	I-PP	O
over	over	IN	I-PP	O
beta	beta	SYM	B-NP	O
blockade	blockade	NN	I-NP	O
or	or	CC	I-NP	O
lithium	lithium	NN	I-NP	O
toxicity	toxicity	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
beta-blocker	beta-blocker	NN	I-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
her	her	PRP$	B-NP	O
lithium	lithium	NN	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
improved	improve	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
50	50	CD	I-NP	O
and	and	CC	O	O
60s	60	NNS	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
would	would	MD	B-VP	O
recommend	recommend	VB	I-VP	O
holding	hold	VBG	I-VP	O
the	the	DT	B-NP	O
beta-blocker	beta-blocker	NN	I-NP	O
until	until	IN	B-SBAR	O
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
at	at	IN	B-PP	O
her	her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
's	's	POS	B-NP	O
office	office	NN	I-NP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
next	next	JJ	I-NP	O
appointment	appointment	NN	I-NP	O
.	.	.	O	O

From	From	IN	B-PP	O
an	an	DT	B-NP	O
ischemia	ischemia	NN	I-NP	O
standpoint	standpoint	NN	I-NP	O
,	,	,	O	O
EKG	EKG	NN	B-NP	B-protein
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
poor	poor	JJ	I-NP	O
study	study	NN	I-NP	O
that	that	WDT	B-NP	O
showed	show	VBD	B-VP	O
perhaps	perhaps	RB	B-ADVP	O
some	some	DT	B-NP	O
T-wave	T-wave	JJ	I-NP	O
inversions	inversion	NNS	I-NP	O
in	in	IN	B-PP	O
aVL	aVL	NN	B-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
ACS	ACS	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
unlikely	unlikely	JJ	B-ADJP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
Acute	Acute	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
on	on	IN	B-PP	O
presentation	presentation	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
1.6	1.6	CD	B-NP	O
and	and	CC	I-NP	O
1.0	1.0	CD	I-NP	O
is	be	VBZ	B-VP	O
likely	likely	JJ	B-ADJP	O
prerenal	prerenal	JJ	B-ADJP	O
versus	versus	IN	B-PP	O
lithium	lithium	NN	B-NP	O
toxicity	toxicity	NN	I-NP	O
versus	versus	IN	B-PP	O
a	a	DT	B-NP	O
combination	combination	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
creatinine	creatinine	NN	I-NP	O
improved	improve	VBD	B-VP	O
to	to	TO	B-PP	O
1.2	1.2	CD	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Endocrinology	Endocrinology	NNP	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
diabetes	diabete	NNS	B-NP	O
according	accord	VBG	B-PP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
medical	medical	JJ	I-NP	O
records	record	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
glucose	glucose	NN	I-NP	O
while	while	IN	B-SBAR	O
admitted	admit	VBN	B-VP	O
here	here	RB	B-ADVP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
between	between	IN	B-NP	O
90	90	CD	I-NP	B-DNA
and	and	CC	I-NP	I-DNA
132	132	CD	I-NP	I-DNA
.	.	.	O	O

These	These	DT	B-NP	O
were	be	VBD	B-VP	O
random	random	JJ	B-NP	O
glucose	glucose	NN	I-NP	O
draws	draw	NNS	I-NP	O
.	.	.	O	O

Hemoglobin	Hemoglobin	NN	B-NP	B-protein
A1c	A1c	NN	I-NP	O
was	be	VBD	B-VP	O
checked	check	VBN	I-VP	O
which	which	WDT	B-NP	O
came	come	VBD	B-VP	O
back	back	RB	B-ADVP	O
at	at	IN	B-PP	O
6.2	6.2	CD	B-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
diabetes	diabete	NNS	B-NP	O
may	may	MD	B-VP	O
or	or	CC	O	O
may	may	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
an	an	DT	B-NP	O
appropriate	appropriate	JJ	I-NP	O
diagnosis	diagnosis	NN	I-NP	O
for	for	IN	B-PP	O
her	her	PRP	B-NP	O
and	and	CC	I-NP	O
she	she	PRP	I-NP	O
should	should	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
fasting	fast	VBG	I-NP	O
blood	blood	NN	I-NP	O
glucose	glucose	NN	I-NP	O
test	test	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Infectious	Infectious	JJ	B-NP	O
disease	disease	NN	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
initial	initial	JJ	B-NP	O
presentation	presentation	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
hypotension	hypotension	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
bradycardia	bradycardia	NN	B-NP	O
and	and	CC	O	O
beta	beta	NN	B-NP	O
blockade	blockade	NN	I-NP	O
with	with	IN	B-PP	O
decreased	decrease	VBN	B-NP	O
volume	volume	NN	I-NP	O
status	status	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
concern	concern	NN	I-NP	O
initially	initially	RB	B-ADVP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
cellulitis	cellulitis	NN	B-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
covered	cover	VBN	I-VP	O
broadly	broadly	RB	B-ADVP	O
with	with	IN	B-PP	O
Unasyn	Unasyn	NN	B-NP	O
and	and	CC	I-NP	O
vancomycin	vancomycin	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
she	she	PRP	B-NP	O
improved	improve	VBD	B-VP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
redness	redness	NN	I-NP	O
and	and	CC	I-NP	O
swelling	swelling	NN	I-NP	O
decreased	decrease	VBD	B-VP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
switched	switch	VBN	I-VP	O
to	to	TO	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
and	and	CC	O	O
committed	commit	VBN	B-VP	O
to	to	TO	I-VP	O
complete	complete	VB	I-VP	O
a	a	DT	B-NP	O
seven-day	seven-day	JJ	I-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
complete	complete	VB	I-VP	O
six	six	CD	B-NP	O
more	more	JJR	I-NP	O
days	day	NNS	I-NP	O
after	after	IN	B-PP	O
discharge	discharge	NN	B-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
of	of	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Deconditioning	Deconditione	VBG	B-VP	O
:	:	:	O	O
As	As	IN	B-SBAR	O
mentioned	mention	VBN	B-VP	O
above	above	RB	B-ADVP	O
,	,	,	O	O
Physical	Physical	JJ	B-NP	O
Therapy	Therapy	NN	I-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
go	go	VB	I-VP	O
to	to	TO	B-PP	O
nursing	nursing	NN	B-NP	O
facility	facility	NN	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
temporary	temporary	JJ	I-NP	O
rehabilitation	rehabilitation	NN	I-NP	O
.	.	.	O	O

Upon	Upon	IN	B-PP	O
discharge	discharge	NN	B-NP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
from	from	IN	B-PP	O
rehab	rehab	NN	B-NP	O
,	,	,	O	O
home	home	NN	B-NP	O
safety	safety	NN	I-NP	O
evaluation	evaluation	NN	I-NP	O
should	should	MD	B-VP	O
take	take	VB	I-VP	O
place	place	NN	B-NP	O
to	to	TO	B-VP	O
make	make	VB	I-VP	O
sure	sure	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
okay	okay	NN	B-NP	O
to	to	TO	B-VP	O
go	go	VB	I-VP	O
back	back	RB	B-ADVP	O
home	home	NN	I-ADVP	O
and	and	CC	O	O
can	can	MD	B-VP	O
give	give	VB	I-VP	O
the	the	DT	B-NP	O
services	service	NNS	I-NP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
needs	need	VBZ	B-VP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Tylenol	Tylenol	NN	B-NP	O
650	650	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
4h	4h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Klonopin	Klonopin	NN	B-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Oxycodone	Oxycodone	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
to	to	TO	B-PP	O
10	10	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
4h	4h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-LST	O
pain	pain	NN	B-NP	O
,	,	,	O	O
please	please	NN	B-NP	O
hold	hold	VBP	B-VP	O
if	if	IN	B-SBAR	O
respiration	respiration	NN	B-NP	O
rate	rate	NN	I-NP	O
is	be	VBZ	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
12	12	CD	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Risperdal	Risperdal	JJ	B-NP	O
0.5	0.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Levofloxacin	Levofloxacin	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
for	for	IN	B-PP	O
six	six	CD	B-NP	O
days	day	NNS	I-NP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
from	from	IN	B-PP	O
Wilgeimante	Wilgeimante	NNP	B-NP	O
Eycis	Eycis	NNP	I-NP	O
Health	Health	NNP	I-NP	O
on	on	IN	B-PP	O
3/18/05	3/18/05	CD	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Ibuprofen	Ibuprofen	NN	B-NP	O
600	600	CD	I-NP	O
mg	mg	NN	I-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
nursing	nursing	NN	I-NP	O
facility	facility	NN	I-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
draw	draw	JJ	B-NP	O
blood	blood	NN	I-NP	O
for	for	IN	B-PP	O
lithium	lithium	NN	B-NP	O
level	level	NN	I-NP	O
checks	check	NNS	I-NP	O
daily	daily	RB	B-ADVP	O
until	until	IN	B-SBAR	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
below	below	IN	B-PP	O
0.5	0.5	CD	B-NP	O
,	,	,	O	O
at	at	IN	B-PP	O
which	which	WDT	B-NP	O
time	time	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
lithium	lithium	NN	B-NP	O
300	300	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Aurelio	Aurelio	NNP	I-NP	O
Gilberto	Gilberto	NNP	I-NP	O
Hencheck	Hencheck	NNP	I-NP	O
at	at	IN	B-PP	O
Li	Li	NNP	B-NP	O
County	County	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
,	,	,	O	O
phone	phone	NN	B-NP	O
number	number	NN	I-NP	O
is	be	VBZ	B-VP	O
875-800-5169	875-800-5169	CD	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
message	message	NN	I-NP	O
was	be	VBD	B-VP	O
left	leave	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
voice	voice	NN	I-NP	O
mail	mail	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
physician	physician	NN	I-NP	O
's	's	POS	B-NP	O
office	office	NN	I-NP	O
to	to	TO	B-VP	O
schedule	schedule	VB	I-VP	O
her	her	PRP	B-NP	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
contact	contact	VB	I-VP	O
her	her	PRP$	B-NP	O
brother	brother	NN	I-NP	O
,	,	,	O	O
Oren	Oren	NNP	B-NP	O
Dad	Dad	NNP	I-NP	O
,	,	,	O	O
at	at	IN	B-PP	O
phone	phone	NN	B-NP	O
number	number	NN	I-NP	O
919-737-1462	919-737-1462	CD	B-NP	O
or	or	CC	I-NP	O
180-116-0215	180-116-0215	CD	I-NP	O
,	,	,	O	O
or	or	CC	O	O
Daren	Daren	NNP	B-NP	O
Perella	Perella	NNP	I-NP	O
at	at	IN	B-PP	O
354-673-2223	354-673-2223	CD	B-NP	O
to	to	TO	B-VP	O
inform	inform	VB	I-VP	O
them	them	PRP	B-NP	O
at	at	IN	B-PP	O
when	when	WRB	B-ADVP	O
the	the	DT	B-NP	O
appointment	appointment	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
requested	request	VBN	I-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
be	be	VB	B-VP	O
seen	see	VBN	I-VP	O
within	within	IN	B-PP	O
two	two	CD	B-NP	O
to	to	TO	I-NP	O
three	three	CD	I-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
2-1857682	2-1857682	CD	B-NP	O
EMSSten	EMSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
CC	CC	NNP	I-NP	O
:	:	:	O	O
Colby	Colby	NNP	B-NP	O
Kopan	Kopan	NNP	I-NP	O
M.D.	M.D.	NNP	I-NP	O
Comho	Comho	NNP	I-NP	O
Street	Street	NNP	I-NP	O
,	,	,	O	O
Sas	Sas	NNP	B-NP	O
Co	Co	NNP	I-NP	O
Lareox	Lareox	NNP	I-NP	O
,	,	,	O	O
Utah	Utah	NNP	B-NP	O
34863	34863	CD	I-NP	O
Ana	Ana	NNP	I-NP	O
CC	CC	NNP	I-NP	O
:	:	:	O	O
Raul	Raul	NNP	B-NP	O
Nagelschmidt	Nagelschmidt	NNP	I-NP	O
MD	MD	NNP	I-NP	O
Lem	Lem	NNP	I-NP	O
Ca	Ca	NNP	I-NP	O
Chi	Chi	NNP	I-NP	O
Son	Son	NNP	I-NP	O
Oak	Oak	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
BEKER	BEKER	NNP	B-NP	O
,	,	,	O	O
ANIBAL	ANIBAL	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
BEIL	BEIL	NNP	B-NP	O
,	,	,	O	O
LYMAN	LYMAN	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
9137784	9137784	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
10/21/05	10/21/05	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
10/21/05	10/21/05	CD	B-NP	O

